132 related articles for article (PubMed ID: 8621601)
1. B-myb promotes S phase and is a downstream target of the negative regulator p107 in human cells.
Sala A; Casella I; Bellon T; Calabretta B; Watson RJ; Peschle C
J Biol Chem; 1996 Apr; 271(16):9363-7. PubMed ID: 8621601
[TBL] [Abstract][Full Text] [Related]
2. Retinoblastoma family proteins induce differentiation and regulate B-myb expression in neuroblastoma cells.
Raschellà G; Tanno B; Bonetto F; Negroni A; Amendola R; Paggi MG
Med Pediatr Oncol; 2001 Jan; 36(1):104-7. PubMed ID: 11464857
[TBL] [Abstract][Full Text] [Related]
3. A B-myb promoter corepressor site facilitates in vivo occupation of the adjacent E2F site by p107 x E2F and p130 x E2F complexes.
Catchpole S; Tavner F; Le Cam L; Sardet C; Watson RJ
J Biol Chem; 2002 Oct; 277(41):39015-24. PubMed ID: 12147683
[TBL] [Abstract][Full Text] [Related]
4. The retinoblastoma family member p107 binds to B-MYB and suppresses its autoregulatory activity.
Sala A; De Luca A; Giordano A; Peschle C
J Biol Chem; 1996 Nov; 271(46):28738-40. PubMed ID: 8910512
[TBL] [Abstract][Full Text] [Related]
5. Retinoblastoma-related protein pRb2/p130 and its binding to the B-myb promoter increase during human neuroblastoma differentiation.
Raschellà G; Tanno B; Bonetto F; Amendola R; Battista T; De Luca A; Giordano A; Paggi MG
J Cell Biochem; 1997 Dec; 67(3):297-303. PubMed ID: 9361185
[TBL] [Abstract][Full Text] [Related]
6. HPV16 E7 oncoprotein deregulates B-myb expression: correlation with targeting of p107/E2F complexes.
Lam EW; Morris JD; Davies R; Crook T; Watson RJ; Vousden KH
EMBO J; 1994 Feb; 13(4):871-8. PubMed ID: 8112300
[TBL] [Abstract][Full Text] [Related]
7. The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain.
Joaquin M; Watson RJ
J Biol Chem; 2003 Nov; 278(45):44255-64. PubMed ID: 12947099
[TBL] [Abstract][Full Text] [Related]
8. B-Myb overcomes a p107-mediated cell proliferation block by interacting with an N-terminal domain of p107.
Joaquin M; Bessa M; Saville MK; Watson RJ
Oncogene; 2002 Nov; 21(52):7923-32. PubMed ID: 12439743
[TBL] [Abstract][Full Text] [Related]
9. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts.
Bennett JD; Farlie PG; Watson RJ
Oncogene; 1996 Sep; 13(5):1073-82. PubMed ID: 8806697
[TBL] [Abstract][Full Text] [Related]
10. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
Li JM; Hu PP; Shen X; Yu Y; Wang XF
Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
[TBL] [Abstract][Full Text] [Related]
11. Cell-cycle regulation of human B-myb transcription.
Lam EW; Bennett JD; Watson RJ
Gene; 1995 Jul; 160(2):277-81. PubMed ID: 7642110
[TBL] [Abstract][Full Text] [Related]
12. Constitutive expression of B-myb can bypass p53-induced Waf1/Cip1-mediated G1 arrest.
Lin D; Fiscella M; O'Connor PM; Jackman J; Chen M; Luo LL; Sala A; Travali S; Appella E; Mercer WE
Proc Natl Acad Sci U S A; 1994 Oct; 91(21):10079-83. PubMed ID: 7937841
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein.
Zhu L; van den Heuvel S; Helin K; Fattaey A; Ewen M; Livingston D; Dyson N; Harlow E
Genes Dev; 1993 Jul; 7(7A):1111-25. PubMed ID: 8319904
[TBL] [Abstract][Full Text] [Related]
14. Mammalian Mip/LIN-9 interacts with either the p107, p130/E2F4 repressor complex or B-Myb in a cell cycle-phase-dependent context distinct from the Drosophila dREAM complex.
Pilkinton M; Sandoval R; Colamonici OR
Oncogene; 2007 Nov; 26(54):7535-43. PubMed ID: 17563750
[TBL] [Abstract][Full Text] [Related]
15. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes.
Hurford RK; Cobrinik D; Lee MH; Dyson N
Genes Dev; 1997 Jun; 11(11):1447-63. PubMed ID: 9192872
[TBL] [Abstract][Full Text] [Related]
16. E2F-1 and a cyclin-like DNA repair enzyme, uracil-DNA glycosylase, provide evidence for an autoregulatory mechanism for transcription.
Walsh MJ; Shue G; Spidoni K; Kapoor A
J Biol Chem; 1995 Mar; 270(10):5289-98. PubMed ID: 7534293
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional repression and growth suppression by the p107 pocket protein.
Starostik P; Chow KN; Dean DC
Mol Cell Biol; 1996 Jul; 16(7):3606-14. PubMed ID: 8668177
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the cell cycle by B-Myb.
Bessa M; Joaquin M; Tavner F; Saville MK; Watson RJ
Blood Cells Mol Dis; 2001; 27(2):416-21. PubMed ID: 11259164
[TBL] [Abstract][Full Text] [Related]
19. B-Myb expression in vascular smooth muscle cells occurs in a cell cycle-dependent fashion and down-regulates promoter activity of type I collagen genes.
Marhamati DJ; Sonenshein GE
J Biol Chem; 1996 Feb; 271(7):3359-65. PubMed ID: 8631934
[TBL] [Abstract][Full Text] [Related]
20. E1A 12S and 13S of the transformation-defective adenovirus type 12 strain CS-1 inactivate proteins of the RB family, permitting transactivation of the E2F-dependent promoter.
Pützer BM; Rumpf H; Rega S; Brockmann D; Esche H
J Virol; 1997 Dec; 71(12):9538-48. PubMed ID: 9371617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
